Professor of Hematology and Head of the Hematology Department at Tenon University Hospital (Paris, France) and current President of the French Society of Angiology.
Professor Elalamy has established an expert center for heparin-induced thrombocytopenia (HIT) diagnosis and management, as well as a research center for thrombotic or bleeding risk stratification with specialized clinical and laboratory activity in platelet studies.
Prof Elalamy has given over 300 symposia and plenary lectures at international congresses, on a diverse range of issues including platelet activation, HIT, hereditary thrombophilia, antithrombotic strategies and resistance to anti-platelet agents. He has written over 200 peer-reviewed articles and collaborated on several books on hemostasis and thrombosis, as well as edited the first French book on HIT and practical guidebooks on direct oral anticoagulants.
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor.
Accept to continue
By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC Magazine, in order to receive email messages concerning the content published in ICTHIC Magazine and related promotional content/activities. Your email address may also be added to this list as a result of signing up to this Website. Personal Data collected: email address, first name, last name, profession.
ICTHIC CONFERENCE Newsletter By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC, in order to receive newsletters concerning the conference, such as Save the date, information about the meeting venue, the publication of the program, registration fees and deadline, abstract submission deadline and oral communication/poster instructions, hotel booking availability and deadline, social program for accompanying persons, the publication of speakers slides, photo/videogallery of the last edition and information about future editions of the conference. Your email address may also be added to this list as a result of signing up to this Website.